Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/09/20 → 30/04/23 |
Keywords
- Neurological disorders
- Huntington's disease
- Clinical trial
Clinical Trial Phase
- Phase I
- Phase II
A Multicenter, Open-label Extension Study to Evaluate the Safety, Pharmacodynamics, and Clinical Effects of WVE-120101 in Patients with Huntington's Disease.
- O'Brien, Terence (Primary Chief Investigator (PCI))
- Burn, Katherine (Project Manager)
Project: Research